Showing results (1-10 of 385) with videos related to
Sort By:
Pageof 39
Anti-Cancer Drug Design|July 20, 2000
Novobiocin-induced VP-16 accumulation and MRP expression in human leukemia and ovarian carcinoma cellsG Rappa, J R Murren, L M Johnson, et al.Oncology (Williston Park, N.Y.)|August 11, 2001
Rationale for non-platinum chemotherapy in advanced NSCLCJ R MurrenCancer Journal (Sudbury, Mass.)|October 19, 2000
Phase I and pharmacokinetic study of novobiocin in combination with VP-16 in patients with refractory malignanciesJ R Murren, S A DiStasio, A Lorico, et al.Clinical Lung Cancer|January 17, 2004
Irinotecan and taxane combinations for non small-cell lung cancerJ R Murren, M DaviesCancer Journal (Sudbury, Mass.)|November 6, 2001
Staging and clinical prognostic factors for small-cell lung cancerA Argiris, J R MurrenCancer Journal (Sudbury, Mass.)|June 23, 2001
Advances in chemotherapy for small cell lung cancer: single-agent activity of newer agentsA Argiris, J R MurrenClinics in Chest Medicine|March 1, 1993
Chemotherapy and radiation for the treatment of non-small-cell lung cancer. A critical reviewJ R Murren, A C BuzaidThe Yale Journal of Biology and Medicine|May 1, 1989
The role of interferons in the treatment of malignant neoplasmsJ R Murren, A C BuzaidSeminars in Oncology|December 10, 1999
Docetaxel and irinotecan, alone and in combination, in the treatment of non-small cell lung cancerA A Adjei, A Argiris, J R MurrenCancer|September 15, 1991
High-dose cisplatin with dacarbazine and tamoxifen in the treatment of metastatic melanomaA C Buzaid, J R Murren, H J DurivagePageof 39